Pulmonary involvement in idiopathic inflammatory myopathies
Thieme. All rights reserved..
Idiopathic inflammatory myopathies are rare systemic diseases with different types of pulmonary manifestations depending on the underlying aetiology; here, interstitial lung diseases (ILD) are the most frequently found patterns depending on the underlying disorder. There is a lack of sufficient prospective studies on this heterogeneous group of patients, particularly in case of ILD being involved. The diagnosis is based upon guideline recommendations for ILD and requires a multidisciplinary discussion within a team with specific expertise in this field. Myositis specific antibodies and myositis associated antibodies form an essential part of the diagnostic tools and may also be associated with a certain phenotype or disease progression. Anti-t-RNA-synthetase antibodies (Anti-ARS) and anti-melanoma differentiation-associated gene 5 antibodies (MDA5) play an important clinical role for treatment the estimation of response and prognosis. The most common ILD patterns are nonspecific interstitial pneumonia (NSIP) and organising pneumonia (OP) or a mixed pattern of both. Treatment is based on systemic steroids and early initiation of other immunosuppressant drugs. Evidence for this is, however, sparse, since most of the studies having investigated treatment modalities are of retrospective nature, even though some new prospective data may be useful for the establishment of treatment pathways in the future.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:78 |
|---|---|
| Enthalten in: |
Pneumologie (Stuttgart, Germany) - 78(2024), 3 vom: 31. März, Seite 167-179 |
| Sprache: |
Deutsch |
|---|
| Weiterer Titel: |
Pulmonale Beteiligung bei idiopathischen inflammatorischen Myopathien |
|---|
| Beteiligte Personen: |
Berger, Melanie [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 01.03.2024 Date Revised 01.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1055/a-2129-3575 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361457804 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361457804 | ||
| 003 | DE-627 | ||
| 005 | 20240301232025.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1055/a-2129-3575 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1313.xml |
| 035 | |a (DE-627)NLM361457804 | ||
| 035 | |a (NLM)37647917 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 100 | 1 | |a Berger, Melanie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pulmonary involvement in idiopathic inflammatory myopathies |
| 246 | 3 | 3 | |a Pulmonale Beteiligung bei idiopathischen inflammatorischen Myopathien |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.03.2024 | ||
| 500 | |a Date Revised 01.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Thieme. All rights reserved. | ||
| 520 | |a Idiopathic inflammatory myopathies are rare systemic diseases with different types of pulmonary manifestations depending on the underlying aetiology; here, interstitial lung diseases (ILD) are the most frequently found patterns depending on the underlying disorder. There is a lack of sufficient prospective studies on this heterogeneous group of patients, particularly in case of ILD being involved. The diagnosis is based upon guideline recommendations for ILD and requires a multidisciplinary discussion within a team with specific expertise in this field. Myositis specific antibodies and myositis associated antibodies form an essential part of the diagnostic tools and may also be associated with a certain phenotype or disease progression. Anti-t-RNA-synthetase antibodies (Anti-ARS) and anti-melanoma differentiation-associated gene 5 antibodies (MDA5) play an important clinical role for treatment the estimation of response and prognosis. The most common ILD patterns are nonspecific interstitial pneumonia (NSIP) and organising pneumonia (OP) or a mixed pattern of both. Treatment is based on systemic steroids and early initiation of other immunosuppressant drugs. Evidence for this is, however, sparse, since most of the studies having investigated treatment modalities are of retrospective nature, even though some new prospective data may be useful for the establishment of treatment pathways in the future | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Autoantibodies |2 NLM | |
| 700 | 1 | |a Zimmermann, Maximilian |e verfasserin |4 aut | |
| 700 | 1 | |a Kreuter, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Strunk, Johannes |e verfasserin |4 aut | |
| 700 | 1 | |a Windisch, Wolfram |e verfasserin |4 aut | |
| 700 | 1 | |a Höppner, Jakob |e verfasserin |4 aut | |
| 700 | 1 | |a Plath, Ilka |e verfasserin |4 aut | |
| 700 | 1 | |a Schumacher, Falk |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pneumologie (Stuttgart, Germany) |d 1990 |g 78(2024), 3 vom: 31. März, Seite 167-179 |w (DE-627)NLM012597422 |x 1438-8790 |7 nnns |
| 773 | 1 | 8 | |g volume:78 |g year:2024 |g number:3 |g day:31 |g month:03 |g pages:167-179 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1055/a-2129-3575 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 78 |j 2024 |e 3 |b 31 |c 03 |h 167-179 | ||